Development of rapidly soluble mebendazole nanosuspension for colorectal cancer
- 18 December 2023
- journal article
- research article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 91, 105276
Abstract
No abstract availableKeywords
Funding Information
- Anusandhan National Research Foundation (SIR/2022/000652)
This publication has 43 references indexed in Scilit:
- Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancerJournal of Cancer Research and Clinical Oncology, 2013
- Fabrication of quercetin nanoparticles by anti-solvent precipitation method for enhanced dissolutionPowder Technology, 2012
- Combining immunotherapy and targeted therapies in cancer treatmentNature Reviews Cancer, 2012
- Solid dispersions in the form of electrospun core-sheath nanofibersInternational Journal of Nanomedicine, 2011
- Physical and chemical stability of drug nanoparticlesAdvanced Drug Delivery Reviews, 2011
- Physical stability of nanosuspensions: Investigation of the role of stabilizers on Ostwald ripeningInternational Journal of Pharmaceutics, 2011
- Production and characterization of Hesperetin nanosuspensions for dermal deliveryInternational Journal of Pharmaceutics, 2009
- Development of ascorbyl palmitate nanocrystals applying the nanosuspension technologyInternational Journal of Pharmaceutics, 2008
- Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazoleJournal of Pharmaceutical and Biomedical Analysis, 2005
- Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effectJournal of Pharmacy and Pharmacology, 2005